Insights: News Releases Kilpatrick Townsend’s Alyson Wooten Featured Speaker at Abbreviated New Drug Application and Paragraph IV Certification: Critical Insights in 2015 Live Webcast
ATLANTA (August 19) -- Kilpatrick Townsend & Stockton announced today that attorney Alyson Wooten will serve as a featured speaker at a live webcast presented by The Knowledge Group. The webcast, which will be held Tuesday, August 25, is titled, “Abbreviated New Drug Application (ANDA) and Paragraph IV Certification: Critical Insights in 2015.”
Dr. Wooten will discuss, “The Use of Inter Partes Review Petitions in Generic Drug Litigation.” Her session will focus on the review of the competing statutes: Hatch-Waxman vs. AIA, strategies for use of IPR in the pharmaceutical context, and special issues with concurrent ANDA litigation.
For more information on the webcast, please click here.
Dr. Wooten, PharmD, focuses her practice on patent litigation across technologies including telecommunication systems, software systems, pharmaceutical and chemical products, medical devices and financial related technologies. She also has significant experience in strategic IP counseling and licensing. Registered as a patent attorney and pharmacist, Dr. Wooten has broad experience in the pharmaceutical industry, including medical services, regulatory, marketing and clinical trial analysis.
For more information about Kilpatrick Townsend, please visit: www.kilpatricktownsend.com.
Follow the firm on Twitter: @KTS_Law.
While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.
DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.
If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.